Why Is Ionis Pharmaceuticals (IONS) Down 7.9% Since Last Earnings Report? [Yahoo! Finance]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: Yahoo! Finance
Will the recent negative trend continue leading up to its next earnings release, or is Ionis Pharmaceuticals due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Ionis Pharmaceuticals, Inc. before we dive into how investors and analysts have reacted as of late. Q4 Earnings & Sales Beat Estimates Ionis reported fourth-quarter 2025 adjusted loss per share of $1.14, narrower than the Zacks Consensus Estimate of a loss of $1.21. In the year-ago period, the company had incurred an adjusted loss of 43 cents. The adjusted earnings exclude compensation expenses related to equity awards. Including this special item, loss was $1.41 per share compared with a loss of 66 cents in the year-ago period. Total revenues were $203 million, which beat the Zacks Consensus Estimate of about $156 million. Revenues declined 10.6% year over year. Quarter in Detail Commercial revenues, which include sales
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- Ionis Pharmaceuticals (IONS) had its price target raised by Barclays PLC from $95.00 to $106.00. They now have an "overweight" rating on the stock.MarketBeat
- Ionis Pharmaceuticals (IONS) had its price target raised by Needham & Company LLC from $103.00 to $105.00. They now have a "buy" rating on the stock.MarketBeat
- Ionis Pharmaceuticals (IONS) had its price target raised by HC Wainwright from $110.00 to $120.00. They now have a "buy" rating on the stock.MarketBeat
- Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority ReviewBusiness Wire
- Ionis Board Shakeup And Valuation Gap Draw Investor Attention [Yahoo! Finance]Yahoo! Finance
IONS
Earnings
- 2/25/26 - Miss
IONS
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/24/26 - Form 144/A
- 3/23/26 - Form 4
- IONS's page on the SEC website